← Back to search
ADVANCED BIOSCIENCE LABORATORIES, INC.
Doing business as ADVANCED BIOSCIENCE LABORATORIES INC
POTOMAC, MD, 20850
Unclaimed
Prime contracting experience
Showing the 50 most recent of 99 records from government sources. Past participation is not evidence of current teaming interest.
| Role | Agency | Description | Vehicle | Obligated | Action date | Period |
|---|---|---|---|---|---|---|
| Prime | Department of Health and Human Services National Institutes of Health | PROCESS AND ANALYTICAL DEVELOPMENT OF BITOX | HHSN271201700010IUSAspending | $1,057,916 | Sep 22, 2026 | Sep 24, 2021 – Sep 26, 2025 |
| Prime | Department of Health and Human Services National Institutes of Health | PROTOTYPE PEDIATRIC ORAL DISSOLVING FILMS FOR THE PREVENTION OF TUBERCULOSIS | 75N93023D00001USAspending | $2,559,631 | Sep 22, 2026 | Sep 30, 2026 – Sep 29, 2028 |
| Prime | Department of Health and Human Services National Institutes of Health | CONTRACT #HHSN272201800009I NEW TASK AWARD ADVANCED BIOSCIENCE LABORATORIES MUCOSAL VACCINE TECHNOLOGIES- | 75N93018D00009USAspending | $425,756 | Sep 21, 2026 | Sep 1, 2020 – Apr 14, 2023 |
| Prime | Department of Health and Human Services National Institutes of Health | CGMP MANUFACTURE OF VHCA8* FOR THE TREATMENT OF PAIN | 75N95022D00023USAspending | $11,506,045 | Sep 11, 2026 | Sep 30, 2022 – Apr 29, 2027 |
| Prime | Department of Health and Human Services National Institutes of Health | EXPERTISE IN USING BITTER TASTE RECEPTOR BLOCKERS TO IMPROVE THE PALATABILITY OF PEDIATRIC MEDICINES: TRAINED HUMAN SENSORY PANELS | 75N93023D00001USAspending | $2,413,956 | Sep 9, 2026 | Jul 1, 2024 – Dec 31, 2026 |
| Prime | Department of Health and Human Services National Institutes of Health | DIAGNOSTIC DEVELOPMENT SERVICES | 75N93023D00015USAspending | $1,010,033 | Sep 8, 2026 | Sep 7, 2026 – Mar 6, 2027 |
| Prime | Department of Health and Human Services National Institutes of Health | SCALABLE, RELIABLE ARTIFICIAL INTELLIGENCE (AI)/MACHINE LEARNING (ML)- DRIVEN INTEGRATION AND INTERROGATION TO MODERNIZE THE STEP PEDIATRIC EXCIPIENT DATABASE | 75N93023D00001USAspending | $2,674,036 | Sep 1, 2026 | Aug 1, 2026 – Jul 31, 2027 |
| Prime | Department of Health and Human Services National Institutes of Health | IGF::OT::IGF NIAID PRECLINICAL DEVELOPMENT SUPPORT - PRODUCTION OF ECD-IG PROTEIN | HHSN272201100021IUSAspending | $7,214,107 | Aug 27, 2026 | Sep 17, 2015 – Jan 31, 2024 |
| Prime | Department of Health and Human Services National Institutes of Health | DIAGNOSTIC PRE-CLINICAL SERVICES PROGRAM | 75N93023D00015USAspending | $637,718 | Aug 10, 2026 | Jun 20, 2023 – Jun 19, 2030 |
| Prime | Department of Health and Human Services National Institutes of Health | EXPERTISE IN USING BITTER TASTE RECEPTOR BLOCKERS TO IMPROVE THE PALATABILITY OF PEDIATRIC MEDICINES: BLOCKER DISCOVERY | 75N93023D00001USAspending | $3,802,507 | Aug 4, 2026 | Jul 1, 2024 – Sep 29, 2027 |
| Prime | Department of Health and Human Services National Institutes of Health | LONG-TERM STABILITY TESTING OF A NANOPARTICLE BASED HIV ENVELOPE CONTAINING VACCINE | HHSN272201700010IUSAspending | $804,692 | Jul 20, 2026 | Jun 10, 2017 – Jun 9, 2024 |
| Prime | Department of Health and Human Services National Institutes of Health | FINAL TRANSITION AND CONTINUED OPERATION OF THE NHP BREEDING COLONY DURING TRANSITION | HHSN272201300002IUSAspending | $2,226,090 | Jul 16, 2026 | Apr 30, 2020 – Feb 28, 2021 |
| Prime | Department of Health and Human Services National Institutes of Health | MATERIAL AND DATA RECEIPT, STORAGE, SHIPPING, AND INVENTORY | 75N93023D00001USAspending | $259,754 | Jul 9, 2026 | Jul 15, 2023 – Jul 14, 2027 |
| Prime | Department of Health and Human Services National Institutes of Health | THE TASK ORDER IS TO SUPPORT CGMP MANUFACTURING OF THE PGT121.414.LS MONOCLONAL ANTIBODY (PGT121.414.LS MAB) DRUG SUBSTANCE FROM AN ESTABLISHED MANUFACTURING PROCESS, COMPLETE THE FILL FINISH OF THE DRUG SUBSTANCE (DS) INTO DRUG PRODUCT (DP), QUALITY | HHSN272201700010IUSAspending | $17,241,407 | Jun 17, 2026 | Jun 10, 2017 – Dec 30, 2028 |
| Prime | Department of Health and Human Services National Institutes of Health | ESSENTIAL CORE ACTIVITIES III | HHSN272201700010IUSAspending | $1,555,875 | Jun 4, 2026 | Jun 10, 2017 – Jun 8, 2027 |
| Prime | Department of Health and Human Services National Institutes of Health | IGF::OT::IGF MATERIAL RECEIPT, STORAGE, SHIPPING AND INVENTORY | HHSN272201600008IUSAspending | $530,846 | May 26, 2026 | Nov 30, 2016 – Jul 14, 2023 |
| Prime | Department of Health and Human Services National Institutes of Health | IGF::OT::IGF NONHUMAN PRIMATE PURCHASE AND HOLDING | HHSN272201600008IUSAspending | $6,072,227 | May 26, 2026 | Jun 29, 2017 – Jun 30, 2021 |
| Prime | Department of Health and Human Services National Institutes of Health | THE CONTRACTOR SHALL PROVIDE EXPERTISE IN ETHNOGRAPHIC RESEARCH RELATED TO THE ENHANCEMENT OF STUDY DRUG ADHERENCE AND UPTAKE IN HUMAN IMMUNODEFICIENCY VIRUS (HIV) PREVENTION TRIALS. | HHSN272201600008IUSAspending | $537,740 | May 26, 2026 | Aug 9, 2018 – Aug 31, 2020 |
| Prime | Department of Health and Human Services National Institutes of Health | STATISTICAL AND PHARMACOMETRIC MODELING SUPPORT FOR HIV NONVACCINE BIOMEDICAL PREVENTION PRODUCT DEVELOPMENT | HHSN272201600008IUSAspending | $807,259 | May 26, 2026 | Sep 1, 2019 – Aug 31, 2021 |
| Prime | Department of Health and Human Services National Institutes of Health | IGF::OT::IGF NIAID PRECLINICAL DEVELOPMENT SUPPORT | HHSN272201700010IUSAspending | $2,407,110 | May 14, 2026 | Aug 28, 2018 – Sep 30, 2031 |
| Prime | Department of Health and Human Services National Institutes of Health | ABL MANUFACTURE AND CHARACTERIZATION SERVICES (MCS) FOR VACCINES AND OTHER BIOLOGICS FOR INFECTIOUS DISEASES | 75N93018D00009USAspending | $3,752,675 | Apr 2, 2026 | May 15, 2022 – Oct 31, 2026 |
| Prime | Department of Health and Human Services National Institutes of Health | QUALITY ASSURANCE/QUALITY CONTROL (QA/QC) SUPPORT | 75N93023D00001USAspending | $2,171,969 | Mar 30, 2026 | Apr 15, 2023 – Apr 14, 2027 |
| Prime | Department of Health and Human Services National Institutes of Health | IGF::OT::IGF NIAID PRECLINICAL DEVELOPMENT SUPPORT- CGMP MANUFACTURING OF PGT121 AND PGDM1400 ANTIBODIES | HHSN272201700010IUSAspending | $12,942,880 | Mar 30, 2026 | Aug 9, 2018 – Dec 31, 2031 |
| Prime | Department of Health and Human Services National Institutes of Health | IGF::OT::IGF PRODUCTION OF ALUMINUM BASED ADJUVANTS | HHSN272201700010IUSAspending | $2,102,618 | Mar 4, 2026 | Sep 20, 2017 – Mar 4, 2026 |
| Prime | Department of Health and Human Services National Institutes of Health | FEASIBILITY FOR DEVELOPMENT OF A LIPOSOME/LNP DISPLAYING AN HIV ENV TRIMER PROTEIN AND CONTAINING/INCORPORATING AN MRNA. | 75N93022D00004USAspending | $3,782,538 | Feb 25, 2026 | Aug 31, 2024 – Aug 27, 2028 |
| Prime | Department of Health and Human Services National Institutes of Health | CONTRACT ABL HHSN272201800009I ALS3 GMP MASTER CELL BANK PRODUCTION AND FORMULATION DEVELOPMENT | 75N93018D00009USAspending | $443,276 | Dec 19, 2025 | Sep 26, 2023 – Mar 31, 2026 |
| Prime | Department of Health and Human Services National Institutes of Health | HHSN272201800009I ADVANCED BIOSCIENCE LABORATORIES, INC PROCESS DEVELOPMENT FOR PANFUNGAL VACCINE BASE AWARD CAN 8470036 FOR $159,189.00 CAN 8470038 FOR $318,377.00 TOTAL $477,566.00 | 75N93018D00009USAspending | $639,462 | Sep 25, 2025 | Jan 20, 2023 – Nov 30, 2025 |
| Prime | Department of Health and Human Services National Institutes of Health | 1800009I ADVANCED BIOSCIENCE LABORATORIES, INC.; TO V4 PIPB--1 BASE TASK ORDER FUNDING; IID CAN 8470036 $173,773 | 75N93018D00009USAspending | $534,190 | Sep 23, 2025 | Apr 15, 2019 – May 14, 2028 |
| Prime | Department of Health and Human Services National Institutes of Health | CGMP MANUFACTURING OF GLYCOPEPTIDE IMMUNOGEN NANOPARTICLE VACCINE | HHSN272201700010IUSAspending | $4,683,305 | Sep 22, 2025 | Sep 16, 2019 – Apr 15, 2025 |
| Prime | Department of Health and Human Services National Institutes of Health | IGF::OT::IGF NIAID PRECLINICAL DEVELOPMENT SUPPORT - PRODUCTION OF CGMP NATIVE FLEXIBLY LINKED HIV-1 ENVELOPE PROTEIN | HHSN272201100021IUSAspending | $9,545,732 | Jul 30, 2025 | Sep 12, 2016 – Mar 31, 2028 |
| Prime | Department of Health and Human Services National Institutes of Health | IGF::OT::IGF NIAID PRECLINICAL DEVELOPMENT SUPPORT - PRODUCTION OF HIV-1GP120 PROTEIN | HHSN272201100021IUSAspending | $4,240,925 | Jul 30, 2025 | Sep 17, 2013 – Jun 30, 2022 |
| Prime | Department of Health and Human Services National Institutes of Health | USE OF ARTIFICIAL INTELLIGENCE/MACHINE LEARNING (AI/ML) TO ENHANCE THE STEP PEDIATRIC EXCIPIENT DATABASE | 75N93023D00001USAspending | $1,193,090 | Jul 18, 2025 | Aug 1, 2024 – Sep 30, 2025 |
| Prime | Department of Health and Human Services National Institutes of Health | THE CONTRACTOR SHALL: (1) PERFORM AND DOCUMENT A QUALITY EVALUATION OF THE STUDY PRODUCT TO CERTIFY THAT IT MEETS THE REGULATORY REQUIREMENTS FOR USE IN STUDIES BY ENSURING THAT THE MANUFACTURING PROCESSES ARE WELL-DOCUMENTED, AND THE RESULTING DATA | HHSN272201600008IUSAspending | $263,619 | Jul 8, 2025 | May 1, 2020 – Apr 30, 2022 |
| Prime | Department of Health and Human Services National Institutes of Health | THE CONTRACTOR SHALL SUPPORT THE ADMINISTRATIVE AND TECHNICAL ACTIVITIES CONDUCTED ON A RECURRING BASIS TO PROVIDE QUALITY ASSURANCE/QUALITY CONTROL (QA/QC) SUPPORT TO TASK ORDERS AWARDED UNDER TASK AREAS A, B, C, AND D. | HHSN272201600008IUSAspending | $2,109,777 | Jul 7, 2025 | Jul 15, 2019 – Jul 14, 2023 |
| Prime | Department of Health and Human Services National Institutes of Health | IGF::OT::IGF NIAID PRECLINICAL DEVELOPMENT SUPPORT - SUPPORT FOR PRODUCTION AND TESTING OF ADC6-HIV GP140 AND ADC7-HIV GP140 | HHSN272201100021IUSAspending | $3,731,476 | Jun 26, 2025 | Aug 25, 2016 – Apr 11, 2025 |
| Prime | Department of Health and Human Services National Institutes of Health | IGF::OT::IGF PRODUCTION OF ADJUVANTS | HHSN272201700010IUSAspending | $1,458,937 | Jun 26, 2025 | Sep 21, 2017 – Apr 15, 2025 |
| Prime | Department of Health and Human Services National Institutes of Health | IGF::OT::IGF FILL-FINISH, RELEASE, AND STABILITY TESTING OF HIV-1 GP120 PROTEINS $2,302,002 ON CAN 17-8470035. | HHSN272201700010IUSAspending | $3,017,609 | Jun 26, 2025 | Sep 20, 2017 – Apr 15, 2025 |
| Prime | Department of Health and Human Services National Institutes of Health | IGF::OT::IGF SIMIAN VACCINE EVALUATION UNITS | HHSN272201300002IUSAspending | $2,185,236 | Jun 11, 2025 | May 1, 2013 – Apr 30, 2020 |
| Prime | Department of Health and Human Services National Institutes of Health | ADMINISTRATIVE AND TECHNICAL SUPPORT FOR ONGOING TASK AREA 3 STUDIES AND FINAL TRANSITION | HHSN272201300002IUSAspending | $462,455 | Jun 11, 2025 | Apr 30, 2020 – Apr 29, 2022 |
| Prime | Department of Health and Human Services National Institutes of Health | IGF::OT::IGF SIMIAN VACCINE EVALUATION UNITS | HHSN272201300002IUSAspending | $964,412 | Jun 11, 2025 | Aug 29, 2017 – Apr 30, 2022 |
| Prime | Department of Health and Human Services National Institutes of Health | IGF::OT::IGF - NIAID PRECLINICAL DEVELOPMENT SUPPORT - PRODUCTION OF THE MHRP GP145 CLADE C TRIMER PROTEIN | HHSN272201100021IUSAspending | $9,967,500 | Jun 6, 2025 | Sep 27, 2012 – Jul 31, 2025 |
| Prime | Department of Health and Human Services National Institutes of Health | MANUFACTURE AND PRECLINICAL TESTING OF SITE BLOCKING OLIGONUCLEOTIDES (SBO) | 75N95022D00023USAspending | $1,899,037 | Jun 3, 2025 | Feb 9, 2024 – Jun 2, 2025 |
| Prime | Department of Health and Human Services National Institutes of Health | CONTRACT HHSN272201800009I ADVANCED BIOSCIENCE LABORATORIIES, INC. OLOGY BASE AWARDPROCESS DEVELOPMENT AND MANUFACTURE OF CGMP COMPLIANT B19 PARVOVIRUS VACCINE DRUG PRODUCT FOR USE IN PHASE I/II CLINICAL TRIALSIID CAN 84702151,803.970 | 75N93018D00009USAspending | $1,663,985 | Apr 21, 2025 | Aug 14, 2019 – Apr 15, 2025 |
| Prime | Department of Health and Human Services National Institutes of Health | IGF::OT::IGF NIAID PRECLINICAL DEVELOPMENT SUPPORT - PRODUCTION OF HCMV-TR3∆PP71 HIVGAG FOR CLINICAL TRIALS | HHSN272201100021IUSAspending | $7,712,780 | Apr 11, 2025 | Sep 26, 2014 – Jun 30, 2025 |
| Prime | Department of Health and Human Services National Institutes of Health | IGF::OT::IGF NIAID PRECLINICAL DEVELOPMENT SUPPORT - PRODUCTION OF A CHIMPANZEE ADENOVIRUS HIV-1 VACCINE | HHSN272201100021IUSAspending | $4,447,235 | Dec 19, 2024 | Sep 15, 2016 – Sep 30, 2028 |
| Prime | Department of Health and Human Services National Institutes of Health | IGF::OT::IGF NIAID PRECLINICAL DEVELOPMENT SUPPORT | HHSN272201700010IUSAspending | $2,696,523 | Dec 19, 2024 | Sep 21, 2017 – Dec 31, 2026 |
| Prime | Department of Health and Human Services National Institutes of Health | IGF::OT::IGF - R&D- MEDICAL: BIOMEDICAL (APPLIED RESEARCH/EXPLORATORY DEVELOPMENT) | — | $4,612,477 | Dec 12, 2024 | Mar 1, 2016 – Feb 7, 2019 |
| Prime | Department of Health and Human Services National Institutes of Health | IGF::OT::IGF SUPPORT FOR RESEARCH ON RETROVIRAL PATHOGENESIS, TREATMENT, AND PREVENTION | — | $3,011,769 | Nov 13, 2024 | Jun 1, 2018 – Jan 29, 2024 |
| Prime | Department of Health and Human Services National Institutes of Health | IGF::OT::IGF SIMIAN VACCINE EVALUATION UNITS | HHSN272201300002IUSAspending | $1,680,664 | Sep 25, 2024 | Sep 17, 2015 – Jun 30, 2019 |
| Prime | Department of Health and Human Services National Institutes of Health | IGF::OT::IGF SIMIAN VACCINE EVALUATION UNITS | HHSN272201300002IUSAspending | $2,833,961 | Sep 25, 2024 | Aug 15, 2016 – Jun 30, 2021 |
Contract vehicles are shown only when present in the source record. Linked award numbers and vehicles open the authoritative record on USAspending.gov.
Agencies supported
- Department of Health and Human ServicesGov-sourced